If you are evaluating a patient suspected to have mpox, immediately report the suspected case to the local health department (LHD) using the Confidential Morbidity Report Portal (Epi-1) or telephone, even if testing is being conducted at a commercial laboratory.
General Information
VDH Clinician Outreach
Webinars
- Virginia Chapter of American College of Physicians Presents: A Current Update on Mpox 12/14/22 (VDH)
- What Healthcare Professionals Need to Know About Mpox 11/2/22 (VDH)
- VDH Mpox Overview for HIV/AIDS Providers
- What Healthcare Professionals Need to Know About Mpox 10/21/22 (VDH)
- Virginia Infection Prevention Training Center: Mpox Update (VDH)
- VDH Mpox Outbreak Briefing for MSV and Virginia Healthcare Providers
Clinician Letters
Testing
Commercial laboratory testing for mpox is available. VDH encourages providers to use commercial laboratories, but this testing is not free. The laboratories will bill private insurance, Medicaid, or Medicare for all testing performed. Providers may find the relevant CPT code for mpox virus testing on each commercial laboratory’s website. Providers who encounter any issues while trying to order testing should contact the laboratory’s client services.
Public health testing through the Division of Consolidated Laboratory Services (DCLS) continues to be available at no cost for patients who meet clinical and epidemiologic criteria; providers should consult with their LHD about this testing.
Labs Conducting Testing and Supporting Information
Specimen Collection
- AMA Orthopoxvirus Pathology and Laboratory/Microbiology CPT Codes
- FDA Safety Communication: For Monkeypox Testing, Use Lesion Swab Samples to Avoid False Results
- NETEC How to Collect a Monkeypox Specimen for Diagnostic Testing
- Preparation and Collection of Specimens (CDC)
- Testing Patients for Mpox (CDC)
Public Health Lab
Infection Prevention & Control
Emergency Transport
Information for Patients and Close Contacts
VDH Mpox Handouts for Patients
Vaccine Information
Special Populations or Settings
Clinical Guidance
CDC Clinician Outreach
Webinars
- CDC COCA Call: Update on Mpox in Children, Adolescents, and People Who Are Pregnant or Breastfeeding
- CDC COCA Call: Situational Update for Clinicians About Severe Mpox Virus Infections
- CDC COCA Call: CDC and FDA Update: Interim Clinical Considerations for Mpox Vaccination
- CDC COCA Call: Mpox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination
- CDC COCA Call: Mpox: Updates about Clinical Diagnosis and Treatment
- CDC COCA Call: What Healthcare Providers Need to Know about Mpox in the United States and Other Countries
- CDC Update on the Use of Medical Countermeasures for Mpox Infection slides July 28, 2022
- CDC/IDSA Clinician Call: Mpox: Updates on Testing, Vaccination & Treatment
CDC Health Advisories
- CDC Health Alert Network (HAN) Health Advisory: Update on Managing Mpox in Patients Receiving Therapeutics (11/18/2022)
- CDC Health Alert Network (HAN) Health Advisory: Severe Manifestations of Mpox among People who are Immunocompromised Due to HIV or Other Conditions (9/29/2022)
- CDC Health Alert Network (HAN) Health Advisory: Update for Clinicians on Mpox in People with HIV, Children and Adolescents, and People who are Pregnant or Breastfeeding (8/1/2022)
- CDC Health Alert Network (HAN) Health Advisory: Update for Clinicians on Testing and Treatment for Mpox (7/28/2022)
- CDC Health Alert Network (HAN) Health Advisory: Updated Case-finding Guidance: Mpox Outbreak—United States (6/14/2022)
- CDC Health Alert Network (HAN) Health Advisory: Mpox Virus Infection in the United States and Other Non-endemic Countries (5/20/2022)
Last updated: March 15, 2023
Opens pdf to download
Opens document to download
Opens in a new window
External link will open in a new window. Click link to exit Virginia Department of Health Website.